PHI with primary biliary cholangitis (PBC)
How does this condition affect your private health insurance?
Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterized by the progressive destruction of small bile ducts within the liver. This damage leads to a buildup of bile acids, causing inflammation and scarring (cirrhosis). Symptoms often include profound fatigue, severe itching (pruritus), dry eyes/mouth, and jaundice in later stages. The disease primarily affects women and can progress slowly over decades. Without treatment, it can lead to end-stage liver failure, necessitating a liver transplant. Early diagnosis and management, typically with ursodeoxycholic acid, aim to slow progression and alleviate symptoms.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms develop insidiously over months to years before diagnosis; acute presentation is rare.
Duration of Illness (Lifetime)
Chronic, progressive disease, lasting decades, often for the remainder of the patient's life once diagnosed.
Cost of Treatment (Initial)
Initial diagnostic work-up (blood tests, imaging, liver biopsy) can cost several thousands of USD. Initial medication regimen costs are ongoing.
Cost of Treatment (Lifetime)
High, involving lifelong medication, regular monitoring, management of complications, and potentially very high costs for liver transplant if necessary (hundreds of thousands of USD).
Mortality Rate
Low in early stages with effective treatment, but increases significantly with progression to end-stage liver disease or complications like portal hypertension without transplant. Mortality is high if untreated or in advanced stages.
Risk of Secondary Damages
High. Common complications include severe fatigue, debilitating pruritus, osteoporosis, malabsorption, portal hypertension, ascites, variceal bleeding, and hepatocellular carcinoma. Psychological impact is also significant.
Probability of Full Recovery
Very low. There is no cure for PBC. Treatment aims to slow progression, manage symptoms, and improve quality of life. Liver transplant can be curative for the liver disease but recurrence in the transplanted liver is possible.
Underlying Disease Risk
High. PBC is frequently associated with other autoimmune conditions, such as Sjögren's syndrome, autoimmune thyroid disease, scleroderma, Raynaud's phenomenon, and celiac disease.